Search Results - "Liu, Yehuan"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Application of quality control circle in the treatment of moderate cancer pain in inpatients by Liu, Yehuan, Lin, Beibei

    Published in Japanese journal of clinical oncology (05-05-2020)
    “…Pain is one of the most common and intolerable symptoms in cancer patients. But cancer pain control is still negative in China. This paper explores the…”
    Get full text
    Journal Article
  2. 2

    Expression profile analysis of long noncoding RNA in HER-2-enriched subtype breast cancer by next-generation sequencing and bioinformatics by Yang, Fan, Lyu, Shixu, Dong, Siyang, Liu, Yehuan, Zhang, Xiaohua, Wang, Ouchen

    Published in OncoTargets and therapy (01-01-2016)
    “…Human epidermal growth factor receptor 2 (HER-2)-enriched subtype breast cancer is associated with a more aggressive phenotype and shorter survival time. Long…”
    Get full text
    Journal Article
  3. 3

    KLP-PI: a new prognostic index for luminal B HER-2-negative breast cancer by Pan, Chuanmeng, Bhandari, Adheesh, Liu, Yehuan, Xia, Erjie, Lin, Lizhi, Lv, Shixu, Wang, Ouchen

    “…Luminal B HER-2-negative (LBHN) subtype is one of the major subtypes of breast cancer according to different features, clinical behaviors, and treatment…”
    Get full text
    Journal Article
  4. 4

    A Novel Preferential Diffusion Recommendation Algorithm Based on User’s Nearest Neighbors by Zhang, Fuguo, Xiong, Qinqiao, Liu, Yehuan

    “…Recommender system is a very efficient way to deal with the problem of information overload for online users. In recent years, network based recommendation…”
    Get full text
    Journal Article
  5. 5

    Low dose of dexamethasone combined with netupitant and palonosetron in preventing nausea and vomiting in breast cancer patients induced by anthracycline drugs by Liu, Yehuan, Hu, Peipei, Jiang, Yiyan, Chen, Xixiu, Li, Suxia

    Published in Clinical & translational oncology (13-07-2024)
    “…To study the effects of various courses of dexamethasone (DEX) combined with 5-HT3 receptor antagonists (RA) and NK-1 RA in suppressing high-grade nausea and…”
    Get full text
    Journal Article
  6. 6

    BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients by Jin, Langping, Chen, Endong, Dong, Siyang, Cai, Yefeng, Zhang, Xiangjian, Zhou, Yili, Zeng, Ruichao, Yang, Fan, Pan, Chuanmeng, Liu, Yehuan, Wu, Weili, Xing, Mingzhao, Zhang, Xiaohua, Wang, Ouchen

    Published in Oncotarget (05-04-2016)
    “…The role of telomerase reverse transcriptase (TERT) gene promoter mutations in the aggressiveness of papillary thyroid cancer (PTC) remains to be further…”
    Get full text
    Journal Article
  7. 7

    C-MYC-induced upregulation of lncRNA SNHG12 regulates cell proliferation, apoptosis and migration in triple-negative breast cancer by Wang, Ouchen, Yang, Fan, Liu, Yehuan, Lv, Lin, Ma, Ruimin, Chen, Chuanzhi, Wang, Jiao, Tan, Qiufan, Cheng, Yue, Xia, Erjie, Chen, Yizuo, Zhang, Xiaohua

    Published in American journal of translational research (01-01-2017)
    “…Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer, with a significantly higher recurrence and mortality rate. There…”
    Get full text
    Journal Article
  8. 8

    IL-27 rs153109 polymorphism increases the risk of colorectal cancer in Chinese Han population by Lyu, Shixu, Ye, Lechi, Wang, Ouchen, Huang, Guanli, Yang, Fan, Liu, Yehuan, Dong, Siyang

    Published in OncoTargets and therapy (01-01-2015)
    “…IL-27, a new member of the IL-12 family, has been found to have antitumor effects in colorectal cancer (CRC); therefore, polymorphisms of this protein may…”
    Get full text
    Journal Article